Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 6/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3640613 | 0.95 | CYP3A4 (0.41) | CYP3A4TDP1LOXL2CYP1A2CYP2C9 | |
| SCHEMBL3640618 | 0.90 | CYP3A4 (0.38) | CYP3A4TDP1LOXL2CYP1A2CYP2C9 | |
| SCHEMBL5414564 | 0.86 | CYP3A4 (0.35) | CYP3A4TDP1LOXL2CYP1A2CYP2C9 | |
| SCHEMBL474250 | 0.78 | CYP3A4 (0.41) | CYP3A4TDP1LOXL2CYP1A2CYP2C9 | |
| Hydrochloric Acid SCHEMBL29241928 | 0.76 | CYP3A4 (0.39) | CYP3A4TDP1LOXL2CYP1A2CYP2C19 | |
| SCHEMBL29192763 | 0.76 | CYP3A4 (0.39) | CYP3A4TDP1LOXL2CYP1A2CYP2C9 | |
| SCHEMBL28479254 | 0.76 | CYP3A4 (0.39) | CYP3A4TDP1LOXL2CYP1A2CYP2C9 | |
| Ethylenediamine SCHEMBL14844095 | 0.76 | TAAR1 (0.39) | CYP3A4TDP1LOXL2CYP1A2CYP2C19 | |
| SCHEMBL27343 | 0.75 | CYP3A4 (0.50) | CYP3A4TDP1LOXL2ESR1ESR2 | |
| SCHEMBL114543 | 0.75 | CYP3A4 (0.50) | CYP3A4TDP1LOXL2CYP1A2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103635421-A | Method for obtaining hydrogen by catalytic decomposition of formic acid | BAYER TECHNOLOGY SERVICES GMBH | 2014-03-12 | — | — | CN | claimed |
| EP-2534161-A1 | ENANTIOMERICALLY ENRICHED AMINODIPHOSPHINES AS LIGANDS FOR THE PREPARATION OF CATALYSTS FOR ASYMMETRIC SYNTHESIS | Enantia, S.L. (ES) | 2012-12-19 | — | — | EP | claimed |
| WO-2011098160-A1 | ENANTIOMERICALLY ENRICHED AMINODIPHOSPHINES AS LIGANDS FOR THE PREPARATION OF CATALYSTS FOR ASYMMETRIC SYNTHESIS | ENANTIA, S.L. (ES) | 2011-08-18 | — | — | WO | claimed |
| CN-122060216-A | Degradation method of epoxy hybrid resin | 赢创运营有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-10581119-B2 | Polymeric ion traps for suppressing or minimizing transition metal ions and dendrite formation or growth in lithium-ion batteries | GM Global Technology Operations LLC (US) | 2020-03-03 | — | — | US | disclosed |
| CN-107955024-B | Using three ((diphenyl phosphine) methylene) amine as the 15 core silver cluster compounds and its synthetic method and antitumor application thereof of ligand | 广西师范大学 | 2019-10-01 | — | — | CN | disclosed |
| CN-109331878-A | A kind of catalyst for ethylene oligomerization | 天津科技大学 | 2019-02-15 | — | — | CN | disclosed |
| US-10179331-B2 | Ligand based chromium catalyst and application in catalyzing ethylene oligomerization | CHINA PETROLEUM & CHEIMCAL CORPORATION (CN) | 2019-01-15 | — | — | US | disclosed |
| US-20190013551-A1 | POLYMERIC ION TRAPS FOR SUPPRESSING OR MINIMIZING TRANSITION METAL IONS AND DENDRITE FORMATION OR GROWTH IN LITHIUM-ION BATTERIES | GM Global Technology Operations LLC | 2019-01-10 | — | — | US | disclosed |
| US-20170275321-A1 | First-Row Transition Metal Hydrogenation and Hydrosilylation Catalysts | UNITED STATES DEPARTMENT OF ENERGY | 2017-09-28 | — | — | US | disclosed |
| US-9708355-B2 | First-row transition metal hydrogenation and hydrosilylation catalysts | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2017-07-18 | — | — | US | disclosed |
| US-20090299645-A1 | Genetic analysis | COLBY, SUSAN | 2009-12-03 | — | — | US | disclosed |
| US-7511183-B2 | Tetramerization of olefins | SASOL TECHNOLOGY (PTY) LIMITED (ZA) | 2009-03-31 | — | — | US | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
| CN-1922148-A | Pyrazole derivatives as protein kinase modulators | ASTEX THERAPEUTICS LTD (GB) | 2007-02-28 | — | — | CN | disclosed |
| US-20060229480-A1 | Tetramerization of olefins | SASOL TECHNOLOGY (PTY) LIMITED (ZA) | 2006-10-12 | — | — | US | disclosed |
| EP-1581342-A1 | TETRAMERIZATION OF OLEFINS | Sasol Technology (Proprietary) Limited (ZA) | 2005-10-05 | — | — | EP | disclosed |
| CN-1538950-A | Method for producton of amines by reductive amination of carbonyl compounds under transfer-hydrogemation conditons | �������¹ɷ�����˾ | 2004-10-20 | — | — | CN | disclosed |
| WO-2004056479-A1 | TETRAMERIZATION OF OLEFINS | SASOL TECHNOLOGY (PTY) LTD (ZA) | 2004-07-08 | — | — | WO | disclosed |
| US-4482718-A | Process for the preparation of 2-(thien-2-yl)- and 2-(thien-3-yl)-ethylamine derivatives | SANOFI (FR) | 1984-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275321-A1 | First-Row Transition Metal Hydrogenation and Hydrosilylation Catalysts | HVCN1, SLC39A3, NECTIN4 | CYP3A4 2652/4885TDP1 3467/4885LOXL2 3543/4885 |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | CYP3A4 1385/4885TDP1 4183/4885LOXL2 155/4885 |
| US-10179331-B2 | Ligand based chromium catalyst and application in catalyzing ethylene oligomerization | CHRNE, NOD2, NOD1 | CYP3A4 2033/4885TDP1 1443/4885LOXL2 1398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.